(2HQ.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:2HQ • US88688T1007
0.679 EUR
-0.04 (-5.19%)
Last: Dec 1, 2025, 07:00 PM
Overall 2HQ gets a fundamental rating of 2 out of 10. We evaluated 2HQ against 55 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of 2HQ have multiple concerns. 2HQ is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year 2HQ has reported negative net income.
- 2HQ had a negative operating cash flow in the past year.
- In the past 5 years 2HQ always reported negative net income.
- In the past 5 years 2HQ reported 4 times negative operating cash flow.
1.2 Ratios
- 2HQ has a worse Return On Assets (-103.13%) than 87.27% of its industry peers.
- 2HQ has a Return On Equity of -139.41%. This is amonst the worse of the industry: 2HQ underperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -103.13% | ||
| ROE | -139.41% | ||
| ROIC | N/A |
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 28.69%, 2HQ is doing worse than 76.36% of the companies in the same industry.
- 2HQ's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for 2HQ so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 28.69% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- 2HQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for 2HQ has been increased compared to 1 year ago.
- 2HQ has more shares outstanding than it did 5 years ago.
- 2HQ has a worse debt/assets ratio than last year.
2.2 Solvency
- 2HQ has an Altman-Z score of -2.63. This is a bad value and indicates that 2HQ is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of 2HQ (-2.63) is worse than 80.00% of its industry peers.
- 2HQ has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
- 2HQ has a better Debt to Equity ratio (0.18) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.63 |
ROIC/WACCN/A
WACC5.65%
2.3 Liquidity
- 2HQ has a Current Ratio of 2.62. This indicates that 2HQ is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of 2HQ (2.62) is better than 85.45% of its industry peers.
- A Quick Ratio of 1.56 indicates that 2HQ should not have too much problems paying its short term obligations.
- 2HQ has a better Quick ratio (1.56) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.62 | ||
| Quick Ratio | 1.56 |
3. Growth
3.1 Past
- The earnings per share for 2HQ have decreased strongly by -6498.00% in the last year.
- 2HQ shows a small growth in Revenue. In the last year, the Revenue has grown by 2.31%.
- Measured over the past years, 2HQ shows a very strong growth in Revenue. The Revenue has been growing by 37.52% on average per year.
EPS 1Y (TTM)-6498%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)2.31%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%4.73%
3.2 Future
- The Earnings Per Share is expected to grow by 14.94% on average over the next years. This is quite good.
- 2HQ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.31% yearly.
EPS Next Y99.61%
EPS Next 2Y41.34%
EPS Next 3Y25.98%
EPS Next 5Y14.94%
Revenue Next Year3.65%
Revenue Next 2Y4.08%
Revenue Next 3Y4.24%
Revenue Next 5Y4.31%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for 2HQ. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 2HQ. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 2HQ is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.73 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as 2HQ's earnings are expected to grow with 25.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.34%
EPS Next 3Y25.98%
5. Dividend
5.1 Amount
- No dividends for 2HQ!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
/ 2HQ.DE FAQ
What is the fundamental rating for 2HQ stock?
ChartMill assigns a fundamental rating of 2 / 10 to 2HQ.DE.
What is the valuation status for 2HQ stock?
ChartMill assigns a valuation rating of 1 / 10 to (2HQ.DE). This can be considered as Overvalued.
Can you provide the profitability details for ?
(2HQ.DE) has a profitability rating of 1 / 10.